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Letter to the editor 
 
Dear Editor, 
A 57-year-old woman had suffered from migraine with aura since childhood. Once or twice 
per month she experienced visual disturbances starting in the right visual field lasting about 
30 min that were followed by strong headaches for 2-3 days accompanied by nausea. 
Occasionally, visual disturbances were associated with naming difficulties. Her migraine 
attacks became less frequent during adolescence (1-2 attacks per year). Occasionally the 
patient took 500 mg paracetamol for her headaches but without much relief.    
At the age of 50 years the frequency of migraine attacks with aura gradually increased. A few 
weeks before presenting to the emergency unit she had 1-2 attacks per week. They were 
associated with dizziness and bilateral lower extremity weakness and were triggered by 
physical exercise. Because of diplopia lasting for 3 hours during two migraine episodes, she 
presented at the emergency unit of a university hospital. The neurological examination 
revealed vertical gaze palsy. Diffusion-weighted MRI showed bilateral cerebellar infarcts and 
ischemic lesions in the right crus cerebri, pons and thalamus. An additional subacute infarct 
was noted on T2-weighted imaging in the left internal capsule. Duplex sonography of extra- 
and intracranial arteries did not reveal any stenoses or signs of atherosclerosis.  Antiplatelet 
therapy with ASS 300 mg/day was initated. She was also taking predisolon 5 mg/d for 
recurrent pain in both calves or unclear etiology for several months. Otherwise her medical 
history was unremarkable. Transthoracic echocardiography revealed a 3.3x2 cm mass in the 
left atrium adherent to the inter-atrial septum with partial contact to the mitral valve, 
suggestive of atrial myxoma. CT scan of the chest confirmed this diagnosis and additionally 
showed a small persistent foramen ovale (PFO). Two weeks later the myxoma was operated 
on and the small PFO was closed. The diagnosis myxoma was verified histologically. The 
patient was anticoagulated with phenprocoumon. Since the operation she has suffered from 
transient double vision once but remained free from auras and headaches (Follow-up 4 
months). Interestingly, her episodes with calve pain had also disappeared.  
The patient’s mother had suffered from migraine without aura, the patient’s daughter suffers 
from migraine with aura, and three nieces (daughters of one brother and 2 different sisters, 
respectively) suffer from migraine. 
 
Comments 
Removal of left atrial myxoma was associated with the disappearance of migraine with aura 
in this patient who had a very high frequency of attacks before the intervention. Cessation of 
migraine attacks after removal of a left atrial myxoma has been described previously (1-4). 
These cases show similarities with our case: (i) History of migraine with complex auras 
including visual, sensory, motor, or aphasic symptoms. (ii) Increase in attack frequency 
during adult life (1-3). (iii) Cerebral infarcts in 3 cases demonstrated on cranial MRI or CT (2-
4).   
Cerebral infarctions are known to be the most frequent neurologic complication of atrial 
myxoma (5). We hypothesise that cardiac emboli might have triggered cortical spreading 
depression (CSD) that is recognized as the pathophysiological correlate of migraine aura, in 
these patients. Recently it has been demonstrated in an animal model that microemboli can 
trigger CSD without causing brain infarctions (6). Thus, depending on the quantity and the 
size of these emboli, CSD alone or in association with embolic infarcts might have occurred. 
The fact that in our patient physical exercise constantly triggered migraine with aura further 
supports this hypothesis because cardiac output increases and so does the likelihood of 
embolus dislodgement.  
Closure of PFO (7) and anticoagulation (8) have been reported to improve migraines. Either 
or both interventions may have contributed to migraine relief in our case. However, both 
measures suggest the same pathomechanism for frequent migraine in this patient, i.e., 
cardioembolism. Considering that the large myxoma is a more likely source of emboli than 
the small PFO, myxoma resection was likely to be the essential intervention here.  
In the conceptual frame of a genetic predisposition to migraine and assuming that PFO and 
myxoma are non-heritable conditions in this patient, the long personal history of migraine 
with aura and the positive family history of migraine suggest that here, embolism is a trigger 
rather than the cause of high-frequency migraine. 
Disappearance of pain in the calves after myxoma resection suggests that this pain might have 
been caused by peripheral embolism.  
Kern et al (3) hypothesised a causal relationship between vasoactive intestinal peptide (VIP) 
secreted by the myxoma and migraine with aura based on the vasoactive properties of this 
peptide. In our myxoma specimen VIP was negative, however, possible other endocrine 
effects cannot be ruled out.  
 
We conclude that echocardiography should be considered in migraine patients with complex 
auras when a significant increase in attack frequency is noted. 
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